Compounds > 2,2-dimethyl-beta-alanine
Page last updated: 2024-08-26

2,2-dimethyl-beta-alanine and Cancer of Prostate

2,2-dimethyl-beta-alanine has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arimoto, MK; Higashi, T; Ishitoya, S; Kagawa, S; Kishibe, Y; Nakamoto, Y; Nishii, R; Oonishi, H; Takahashi, M; Togashi, K; Yamauchi, H1
Fozing, T; Kirsch, CM; Samnick, S1

Trials

1 trial(s) available for 2,2-dimethyl-beta-alanine and Cancer of Prostate

ArticleYear
(11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET.
    Annals of nuclear medicine, 2016, Volume: 30, Issue:8

    Topics: Aged; beta-Alanine; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms

2016

Other Studies

1 other study(ies) available for 2,2-dimethyl-beta-alanine and Cancer of Prostate

ArticleYear
Preparation and tumor affinity testing of the radioiodinated tetrahydroisoquinoline derivative [123I]TIC(OH) for targeting prostate cancer.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2006, Volume: 64, Issue:5

    Topics: Amino Acids; beta-Alanine; Biological Transport; Cell Line, Tumor; Humans; Iodine Radioisotopes; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Scintillation Counting; Tetrahydroisoquinolines

2006